Leading global pharmaceutical company Lupin Limited (Lupin) recently announced positive news regarding their Aurangabad manufacturing facility in India. The company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) following an inspection conducted from March 6th to March 15th, 2024. The US FDA classification of “Voluntary Action …